Financials data is unavailable for this security.
View more
Year on year Pharma-Bio Serv Inc had revenues fall -12.48% from 19.40m to 16.98m, though the company grew net income 30.15% from 1.01m to 1.31m.
| Gross margin | 25.24% |
|---|---|
| Net profit margin | -7.80% |
| Operating margin | -11.00% |
| Return on assets | -4.59% |
|---|---|
| Return on equity | -5.63% |
| Return on investment | -5.21% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Pharma-Bio Serv Inc fell by 4.02m. However, the company earned 1.89m from its operations for a Cash Flow Margin of 11.14%. In addition the company used 4.22m on investing activities and also paid 1.76m in financing cash flows.
| Cash flow per share | -0.0355 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.5962 |
|---|---|
| Tangible book value per share | 0.5962 |
More ▼
Balance sheet in USDView more
| Current ratio | 8.39 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items increased 30.34%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| EPS growth(5 years) | -1.76 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -155.00 |
